Search results
Results From The WOW.Com Content Network
Management of tuberculosis refers to techniques and procedures utilized for treating tuberculosis (TB), or simply a treatment plan for TB. The medical standard for active TB is a short course treatment involving a combination of isoniazid , rifampicin (also known as Rifampin), pyrazinamide , and ethambutol for the first two months.
Tuberculosis phototherapy treatment in Kuopio, Finland, 1934. Treatment of TB uses antibiotics to kill the bacteria. Effective TB treatment is difficult, due to the unusual structure and chemical composition of the mycobacterial cell wall, which hinders the entry of drugs and makes many antibiotics ineffective. [137]
Tuberculosis treatment. Tuberculosis patients, both active and inactive, are treated with antibiotics. Treatment typically involves taking multiple antibiotics every day over a period of four to ...
How is tuberculosis treated? There is a Bacille Calmette-Guérin vaccine for TB disease. It is “not generally used in the United States,” the CDC said, but healthcare providers in countries ...
Directly observed treatment, short-course (DOTS, also known as TB-DOTS) is the name given to the tuberculosis (TB) control strategy recommended by the World Health Organization. [1] According to WHO, "The most cost-effective way to stop the spread of TB in communities with a high incidence is by curing it.
The tuberculosis outbreak in Kansas has many people wondering if there is a vaccine for TB in the U.S. ... Both active and inactive tuberculosis infections can be treated with a six-month course ...
Isoniazid, also known as isonicotinic acid hydrazide (INH), is an antibiotic used for the treatment of tuberculosis. [4] For active tuberculosis, it is often used together with rifampicin, pyrazinamide, and either streptomycin or ethambutol. [5] For latent tuberculosis, it is often used alone. [4]
To give treatment for latent tuberculosis to someone with active tuberculosis is a serious error: the tuberculosis will not be adequately treated and there is a serious risk of developing drug-resistant strains of TB. There are several treatment regimens currently in use: